Guidelines, so many guidelines
- With 5 sets of guidelines emerging from ESC 2019, primary care clinicians may find the pocket versions, available here, to be most accessible.
- Guidelines of special interest for primary care include:
- Management of chronic coronary syndrome, featuring the first recommendations on limited exposure to air and noise pollution and with a major emphasis on lifestyle modifications.
- Management of diabetes and prediabetes with cardiovascular disease, also emphasising lifestyle changes for primary prevention and firstline dual therapy for hypertension.
- Updated cholesterol guidelines that call for a new low for low-density lipoprotein cholesterol targets:
Immunizing against influenza ... and heart attacks?
- In patients with hypertension, annual influenza vaccination is linked to an 18% reduced risk for death.
- The authors of this Danish registry study found reductions in both all-cause and cardiovascular mortality and in acute myocardial infarction and stroke.
A diabetes drug that reduces heart failure death
- The audience broke into spontaneous applause when researchers announced that the diabetes drug dapagliflozin was linked to reduced risk for heart failure death or hospitalisation--diabetes or not.
An aspirin a day does not keep disability at bay
- In healthy older patients, daily low-dose aspirin had no effect on survival or disability-free survival in an Australian trial, but bleeding risk was more than doubled.
- These authors concluded that aspirin should not be recommended as cardiovascular disease prevention for healthy older people over age 70.
High BMI at a young age poses major risks for the heart
- A registry study covering almost 1.7 million 18-year-old men in Sweden, followed for up to 46 years, linked higher BMI and the risk for heart attack before age 65.
- For adolescents in the highest BMI categories, this risk was more than tripled.
- These authors urge attention to early obesity prevention.